Under Armour (NYSE: UA) will try to beat its earnings estimates for the fifth consecutive quarter. The company will unveil its latest earnings on Tuesday, July 26. Under Armour is a developer, marketer and distributor of branded performance apparel, footwear, and accessories for men, women and youth.

What analysts say:

  • Buy, sell, or hold?: Analysts think investors should stand pat on Under Armour, with 14 of 22 analysts rating it a hold. Analysts don't like Under Armour as much as competitor Hanesbrands overall. Six out of nine analysts rate Hanesbrands a buy, compared with six of 22 for Under Armour. Analysts still rate the stock a hold, but they are a bit more wary about it compared with three months ago.
  • Revenue forecasts: On average, analysts predict $273.6 million in revenue this quarter. That would represent a rise of 33.6% from the year-ago quarter.
  • Wall Street earnings expectations: The average analyst estimate is earnings of $0.09 per share. Estimates range from $0.05 to $0.12.

What our community says:
CAPS All-Stars are solidly backing the stock, with 96.6% assigning it an "outperform" rating. The community at large agrees with the All-Stars, with 91.9% giving it a rating of "outperform." Fools have embraced Under Armour and haven't been shy with their opinions lately, logging 1,066 posts in the past 30 days. Even with a robust four out of five stars, Under Armour's CAPS rating falls a little short of the community's upbeat outlook.

Management:
Under Armour's profit has risen year over year by an average of 74.2%.

Now let's look at how efficient management is at running the business. Traditionally, margins represent the efficiency with which companies capture portions of sales dollars. The following table shows gross, operating, and net margins over the past four quarters. 

Quarter Q1 Q4 Q3 Q2
Gross Margin 46.4% 51.7% 50.9% 48.8%
Operating Margin 6.8% 11.7% 17.3% 3.4%
Net Margin 3.9% 7.6% 10.6% 1.7%
One final thing: If you want to keep tabs on Under Armour's movements, and for more analysis on the company, make sure you add it to your Watchlist.